# Innovent Biologics

From Outsourcing to Outpacing: China’s Biotech Leap Triggers Alarm in Washington

Pfizer’s multi-billion dollar partnership with Innovent Biologics underscores China’s rapid ascent from a pharmaceutical follower to a global innovation hub. As Chinese firms begin to outperform Western incumbents in clinical trials and regulatory speed, Washington is increasingly viewing the biotech sector through a lens of national security and competition.